Themis Medicare (THEMISMED) | Financial Analysis & Statements
Themis Medicare Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
975.8M
Gross Profit
451.8M
46.30%
Operating Income
-126.3M
-12.95%
Net Income
-142.2M
-14.57%
EPS (Diluted)
₹-1.54
Balance Sheet Metrics
Total Assets
5.9B
Total Liabilities
1.9B
Shareholders Equity
4.0B
Debt to Equity
0.46
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Themis Medicare Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 4.0B | 3.8B | 3.4B | 3.9B | 2.3B |
| Cost of Goods Sold | 1.3B | 1.4B | 1.2B | 1.5B | 805.3M |
| Gross Profit | 2.7B | 2.4B | 2.2B | 2.4B | 1.5B |
| Gross Margin % | 66.5% | 62.9% | 64.9% | 61.2% | 64.9% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 380.9M | 332.6M | 263.7M | 278.5M | 161.6M |
| Other Operating Expenses | 843.7M | 726.6M | 715.5M | 661.8M | 436.6M |
| Total Operating Expenses | 1.2B | 1.1B | 979.2M | 940.3M | 598.2M |
| Operating Income | 391.5M | 392.6M | 569.6M | 861.6M | 409.5M |
| Operating Margin % | 9.8% | 10.4% | 16.5% | 22.0% | 17.9% |
| Non-Operating Items | |||||
| Interest Income | 11.2M | 8.4M | 5.5M | 6.1M | 4.1M |
| Interest Expense | 84.9M | 76.3M | 79.9M | 65.4M | 109.7M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 396.7M | 534.4M | 725.1M | 952.6M | 413.3M |
| Income Tax | 98.4M | 99.2M | 156.1M | 223.8M | 56.3M |
| Effective Tax Rate % | 24.8% | 18.6% | 21.5% | 23.5% | 13.6% |
| Net Income | 298.3M | 435.2M | 569.0M | 728.8M | 357.0M |
| Net Margin % | 7.5% | 11.6% | 16.5% | 18.6% | 15.6% |
| Key Metrics | |||||
| EBITDA | 581.3M | 732.3M | 909.5M | 1.1B | 608.2M |
| EPS (Basic) | ₹3.24 | ₹4.73 | ₹6.18 | ₹7.92 | ₹3.89 |
| EPS (Diluted) | ₹3.24 | ₹4.72 | ₹6.17 | ₹7.91 | ₹3.88 |
| Basic Shares Outstanding | 92040120 | 92040120 | 92027700 | 92002700 | 91884540 |
| Diluted Shares Outstanding | 92040120 | 92040120 | 92027700 | 92002700 | 91884540 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Themis Medicare Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 65.6M | 99.2M | 125.5M | 202.8M | 190.2M |
| Short-term Investments | 124.9M | 144.8M | 112.6M | 111.6M | 109.4M |
| Accounts Receivable | 1.8B | 1.8B | 1.5B | 1.0B | 776.1M |
| Inventory | 843.1M | 705.7M | 689.5M | 608.1M | 584.9M |
| Other Current Assets | 10.5M | 10.5M | 10.5M | 10.5M | 10.9M |
| Total Current Assets | 3.0B | 2.9B | 2.6B | 2.1B | 1.9B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 56.4M | 54.7M | 52.6M | 51.3M | 50.1M |
| Goodwill | 3.3M | 5.5M | 7.7M | 9.9M | 12.1M |
| Intangible Assets | 3.3M | 5.5M | 7.7M | 9.9M | 12.1M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 133.4M | 124.6M | 142.6M | 89.3M | -54.0K |
| Total Non-Current Assets | 2.8B | 2.7B | 2.5B | 2.1B | 1.9B |
| Total Assets | 5.9B | 5.7B | 5.1B | 4.3B | 3.7B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 514.4M | 472.9M | 400.4M | 318.7M | 307.9M |
| Short-term Debt | 643.8M | 690.2M | 639.3M | 554.3M | 638.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 55.0M | 43.0M | 44.3M | 40.3M | 41.8M |
| Total Current Liabilities | 1.6B | 1.5B | 1.4B | 1.1B | 1.3B |
| Non-Current Liabilities | |||||
| Long-term Debt | 186.1M | 267.7M | 284.5M | 243.0M | 233.8M |
| Deferred Tax Liabilities | 88.3M | 73.9M | 69.4M | 64.7M | 9.5M |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | 293.1M | 341.7M | 353.9M | 307.7M | 243.3M |
| Total Liabilities | 1.9B | 1.9B | 1.7B | 1.4B | 1.5B |
| Equity | |||||
| Common Stock | 92.0M | 92.0M | 92.0M | 92.0M | 91.9M |
| Retained Earnings | 2.6B | 2.3B | 1.9B | 1.4B | 717.2M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 4.0B | 3.8B | 3.4B | 2.9B | 2.2B |
| Key Metrics | |||||
| Total Debt | 829.9M | 957.9M | 923.8M | 797.3M | 871.8M |
| Working Capital | 1.5B | 1.4B | 1.3B | 1.0B | 571.6M |
Balance Sheet Composition
Themis Medicare Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 396.7M | 534.4M | 725.1M | 952.6M | 413.3M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -99.4M | -288.0M | -490.0M | -435.8M | 71.0M |
| Operating Cash Flow | 382.2M | 322.7M | 315.1M | 582.2M | 594.0M |
| Investing Activities | |||||
| Capital Expenditures | -137.4M | -183.9M | -287.1M | -193.0M | -179.9M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | - | 0 | 0 | 0 | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -137.4M | -183.9M | -287.1M | -193.0M | -179.9M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -46.0M | -46.0M | -46.0M | -39.6M | -16.1M |
| Debt Issuance | - | - | - | - | 72.6M |
| Debt Repayment | - | - | - | - | -196.9M |
| Financing Cash Flow | -92.4M | 9.5M | 43.3M | -118.5M | -276.7M |
| Free Cash Flow | 192.8M | 36.8M | -126.6M | 137.7M | 389.4M |
| Net Change in Cash | 152.3M | 148.2M | 71.2M | 270.7M | 137.3M |
Cash Flow Trend
Themis Medicare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
32.38
Price to Book
2.22
Price to Sales
2.50
PEG Ratio
0.02
Profitability Ratios
Profit Margin
-5.16%
Operating Margin
7.99%
Return on Equity
7.41%
Return on Assets
5.07%
Financial Health
Current Ratio
1.72
Debt to Equity
25.15
Beta
0.06
Per Share Data
EPS (TTM)
₹-1.89
Book Value per Share
₹40.99
Revenue per Share
₹36.63
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| THEMISMED | 8.6B | 32.38 | 2.22 | 7.41% | -5.16% | 25.15 |
| Sun Pharmaceutical | 3.9T | 36.73 | 5.15 | 15.08% | 19.21% | 6.68 |
| Divi's Laboratories | 1.7T | 67.11 | 10.82 | 14.64% | 24.04% | 0.58 |
| Sun Pharma Advanced | 46.7B | -13.65 | -13.55 | 157.88% | -53.22% | -1.21 |
| Innova Captab | 41.4B | 31.20 | 4.05 | 13.37% | 8.85% | 32.95 |
| Gujarat Themis | 35.4B | 73.73 | 13.36 | 19.64% | 29.99% | 27.04 |
Financial data is updated regularly. All figures are in the company's reporting currency.





